Pittenger & Anderson Inc’s Bristol-Myers Squibb BMY Stock Holding History

Pittenger & Anderson Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112K	Hold	1,849	–	–	﹤0.01%	263
2025 Q4	$99.7K	Hold	1,849	–	–	﹤0.01%	268
2025 Q3	$83.4K	Hold	1,849	–	–	﹤0.01%	278
2025 Q2	$85.6K	Hold	1,849	–	–	﹤0.01%	263
2025 Q1	$113K	Hold	1,849	–	–	﹤0.01%	242
2024 Q4	$105K	Sell	1,849 -720	-28%	-$40.2K	﹤0.01%	260
2024 Q3	$133K	Hold	2,569	–	–	0.01%	257
2024 Q2	$107K	Hold	2,569	–	–	﹤0.01%	259
2024 Q1	$139K	Buy	2,569 +1,024	+66%	+$52.2K	0.01%	247
2023 Q4	$79.3K	Hold	1,545	–	–	﹤0.01%	271
2023 Q3	$89.7K	Sell	1,545 -1,600	-51%	-$98K	﹤0.01%	251
2023 Q2	$201K	Buy	3,145 +200	+7%	+$13.4K	0.01%	205
2023 Q1	$204K	Hold	2,945	–	–	0.01%	198
2022 Q4	$212K	Sell	2,945 -400	-12%	-$30.2K	0.01%	189
2022 Q3	$238K	Hold	3,345	–	–	0.01%	184
2022 Q2	$258K	Hold	3,345	–	–	0.02%	181
2022 Q1	$244K	Sell	3,345 -3,430	-51%	-$230K	0.01%	199
2021 Q4	$422K	Sell	6,775 -82,241	-92%	-$4.82M	0.02%	173
2021 Q3	$5.27M	Sell	89,016 -9,744	-10%	-$642K	0.26%	95
2021 Q2	$6.6M	Buy	98,760 +595	+0.6%	+$38.8K	0.34%	86
2021 Q1	$6.2M	Sell	98,165 -2,400	-2%	-$149K	0.33%	87
2020 Q4	$6.24M	Buy	100,565 +725	+0.7%	+$44.6K	0.35%	81
2020 Q3	$6.02M	Buy	99,840 +4,322	+5%	+$260K	0.38%	75
2020 Q2	$5.62M	Buy	95,518 +344	+0.4%	+$20.6K	0.4%	77
2020 Q1	$5.3M	Buy	95,174 +17,019	+22%	+$1.04M	0.45%	64
2019 Q4	$5.02M	Buy	78,155 +22,525	+40%	+$1.29M	0.34%	78
2019 Q3	$2.82M	Sell	55,630 -19,570	-26%	-$920K	0.2%	119
2019 Q2	$3.41M	Buy	75,200 +5,700	+8%	+$266K	0.26%	106
2019 Q1	$3.32M	Buy	69,500 +58,000	+504%	+$2.89M	0.26%	104
2018 Q4	$598K	Buy	11,500 +2,000	+21%	+$107K	0.05%	177
2018 Q3	$590K	Hold	9,500	–	–	0.05%	187
2018 Q2	$526K	Hold	9,500	–	–	0.05%	188
2018 Q1	$601K	Sell	9,500 -650	-6%	-$41.8K	0.05%	186
2017 Q4	$622K	Buy	10,150 +615	+6%	+$38.5K	0.05%	187
2017 Q3	$608K	Buy	9,535 +335	+4%	+$19.6K	0.06%	183
2017 Q2	$513K	Sell	9,200 -3,250	-26%	-$177K	0.05%	188
2017 Q1	$677K	Buy	12,450 +2,800	+29%	+$154K	0.07%	178
2016 Q4	$564K	Buy	9,650 +40	+0.4%	+$2.19K	0.06%	185
2016 Q3	$518K	Buy	9,610 +4,110	+75%	+$264K	0.06%	189
2016 Q2	$405K	Hold	5,500	–	–	0.04%	201
2016 Q1	$351K	Hold	5,500	–	–	0.04%	218
2015 Q4	$378K	Hold	5,500	–	–	0.05%	218
2015 Q3	$326K	Hold	5,500	–	–	0.04%	234
2015 Q2	$366K	Buy	5,500 +1,000	+22%	+$65.9K	0.05%	231
2015 Q1	$290K	Hold	4,500	–	–	0.04%	235
2014 Q4	$266K	Hold	4,500	–	–	0.04%	230
2014 Q3	$230K	Hold	4,500	–	–	0.03%	231
2014 Q2	$218K	Hold	4,500	–	–	0.03%	239
2014 Q1	$234K	Hold	4,500	–	–	0.03%	274
2013 Q4	$239K	Hold	4,500	–	–	0.03%	274
2013 Q3	$208K	Hold	4,500	–	–	0.03%	268
2013 Q2	$201K	Buy	+4,500	New	+$195K	0.03%	269

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pittenger & Anderson Inc's BMY Position: Q1 2026 in Review

Pittenger & Anderson Inc held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 1,849 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

Pittenger & Anderson Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.6M in Q2 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Pittenger & Anderson Inc held 1,849 shares of Bristol-Myers Squibb worth $112K as of Q1 2026.
Pittenger & Anderson Inc left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q1 2026, its #263 holding.
Pittenger & Anderson Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Pittenger & Anderson Inc's Bristol-Myers Squibb position peaked at $6.6M in Q2 2021.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2026, filed 1 May 2026.